Plateau estimates 11,000 TB burden as 2,047 patients start treatment
Plateau State health officials estimate that the state has a tuberculosis burden of about 11,000 cases in 2026, as authorities intensify efforts to identify people with the disease and connect them to treatment.
Yohanna Bot, Monitoring and Evaluation Officer of the Plateau State Tuberculosis and Leprosy Control Programme, said 2,047 patients were identified and placed on treatment between July and September.
The estimated 11,000-case burden is based on a tuberculosis prevalence rate of 219 cases per 100,000 people.
It is an estimate of disease burden, not a count of 11,000 laboratory-confirmed patients.
2,047 patients identified in three months
The 2,047 people identified during the July-to-September quarter were placed on treatment at health facilities across Plateau State, according to the programme.
That figure measures recent case detection and treatment initiation.
It should not be subtracted directly from the estimated 11,000 burden to produce a definitive number of untreated people because the two figures have different statistical bases and cover different periods.
Insecurity and displacement complicate access
Programme officials say insecurity and displacement are making tuberculosis detection and treatment more difficult in parts of Plateau, including Mangu, Jos South and Barkin Ladi local government areas.
Mobile and displaced populations can be harder for health services to reach consistently, while crowded living conditions can increase public-health pressures.
The state programme says it is expanding community outreach and active screening, including among displaced populations and in correctional facilities.
Programme official raises medicine-supply concerns
Bot also reported shortages of anti-tuberculosis medicines and linked supply pressure to disruptions in the supply chain and reliance on international support.
The claim makes reliable medicine availability an important accountability issue alongside case detection.
However, the available figures do not establish that every TB patient in Plateau has experienced medicine interruption.
They also do not provide a statewide treatment-completion rate.
Stigma remains a barrier
Health officials have also identified stigma and misconceptions about tuberculosis as obstacles to early diagnosis and treatment.
The programme is combining screening with community awareness efforts aimed at encouraging people with symptoms to seek testing and care earlier.
Accountability questions remain
The central questions are how quickly Plateau can expand case detection, whether anti-TB medicines remain consistently available and whether displaced and hard-to-reach populations can access testing and complete treatment.
There is also a financing question over how much of the state’s tuberculosis response can be sustained domestically if external funding or medicine supply is disrupted.
The available figures indicate a substantial estimated disease burden and recent case-finding activity, but they do not establish how many people in Plateau currently have undiagnosed or untreated tuberculosis.